{"doi":"10.1093/scan/nsp053","title":"The principled control of false positives in neuroimaging","abstract":null,"journal":"Social Cognitive and Affective Neuroscience","year":2009,"id":28225,"datarank":11.561932052592594,"base_score":6.206575926724928,"endowment":6.206575926724928,"self_citation_contribution":0.9309863890087393,"citation_network_contribution":10.630945663583855,"self_endowment_contribution":0.9309863890087393,"citer_contribution":10.630945663583855,"corpus_percentile":null,"corpus_rank":null,"citation_count":495,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":10,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":158648,"name":"George L. Wolford","orcid":null,"position":1,"is_corresponding":false},{"id":79897,"name":"Michael B. Miller","orcid":"0000-0002-6205-3314","position":2,"is_corresponding":false},{"id":158647,"name":"Craig M. Bennett","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":6.206575926724928,"endowment":6.206575926724928,"datacite_reuse_total":10,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"20042432","pmcid":"PMC2799957","openalex_id":"https://openalex.org/W2102122784","authors":[],"funders":[],"total_grants":0,"fwci":9.3645,"citation_percentile":0.98356717,"influential_citations":30,"citation_trend":[{"year":2012,"count":14},{"year":2013,"count":21},{"year":2014,"count":33},{"year":2015,"count":42},{"year":2016,"count":46},{"year":2017,"count":47},{"year":2018,"count":28},{"year":2019,"count":90},{"year":2020,"count":33},{"year":2021,"count":27},{"year":2022,"count":19},{"year":2023,"count":24},{"year":2024,"count":21},{"year":2025,"count":23},{"year":2026,"count":7}],"oa_status":"hybrid","license":"cc-by-nc","oa_locations":[{"url":"https://academic.oup.com/scan/article-pdf/4/4/417/27105926/nsp053.pdf","host_type":"journal"},{"url":"https://academic.oup.com/scan/article-pdf/4/4/417/27105926/nsp053.pdf","host_type":"HYBRID"},{"url":"https://academic.oup.com/scan/article-pdf/4/4/417/27105926/nsp053.pdf","host_type":"publisher"},{"url":"http://academic.oup.com/scan/article-pdf/4/4/417/27105926/nsp053.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1093/scan/nsp053","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/20042432","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2799957","host_type":"repository"}],"fields_of_study":["Statistical Methods in Clinical Trials","Functional Brain Connectivity Studies","Meta-analysis and systematic reviews","Psychology","Medicine","Brain","Brain Mapping","Data Interpretation, Statistical","False Positive Reactions","Humans","Magnetic Resonance Imaging"],"mesh_terms":["Brain","Brain Mapping","Data Interpretation, Statistical","False Positive Reactions","Humans","Magnetic Resonance Imaging"],"keywords":["False positive paradox","False discovery rate","Neuroimaging","Multiple comparisons problem","False positives and false negatives","True positive rate","False positive rate","Computer science","Artificial intelligence","Psychology","Cognitive psychology","Statistics","Mathematics","Neuroscience"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Peace, Justice and strong institutions"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.26613751.v1","title":"Additional file 1 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613751","title":"Additional file 1 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613754.v1","title":"Additional file 2 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613754","title":"Additional file 2 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613757.v1","title":"Additional file 3 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613757","title":"Additional file 3 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613760.v1","title":"Additional file 4 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613760","title":"Additional file 4 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613763.v1","title":"Additional file 5 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26613763","title":"Additional file 5 of Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T20:56:36.073494Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}